| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2025 | Mar 4, 2025 | Evolent Health, Inc. | CFO | Sell | 97.5 | +112,577 | 65.75% | ✗ | $318.8K |
| Aug 22, 2024 | Aug 26, 2024 | Evolent Health, Inc. | CFO | Sell | 10.0 | -44,693 | -20.70% | ✓ | $1.3M |
| Mar 1, 2024 | Mar 5, 2024 | Evolent Health, Inc. | CFO | Sell | 40.0 | -8,110 | -3.62% | ✗ | $696.2K |
| Feb 22, 2024 | Feb 26, 2024 | Evolent Health, Inc. | CFO | Sell | 97.5 | +23,994 | 12.00% | ✗ | $660.8K |
| Mar 1, 2023 | Mar 3, 2023 | Evolent Health, Inc. | CFO | Sell | 90.0 | +7,712 | 4.01% | ✗ | $446.8K |
| Feb 21, 2023 | Feb 23, 2023 | Evolent Health, Inc. | CFO | Sell | 97.5 | +23,975 | 14.24% | ✗ | $562.3K |
| Aug 17, 2022 | Aug 18, 2022 | Evolent Health, Inc. | CFO | Sell | 20.0 | -18,434 | -9.87% | ✗ | $628.8K |
| Mar 2, 2022 | Mar 4, 2022 | Evolent Health, Inc. | CFO | Sell | 37.5 | -41,364 | -18.13% | ✗ | $1.1M |
| Mar 1, 2022 | Mar 3, 2022 | Evolent Health, Inc. | CFO | Sell | 95.0 | +19,490 | 14.23% | ✗ | $123.6K |